GABA-AT | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

48,519 results for “GABA-AT”

Trials

View all 15495 →

Relative Oral Bioavailability of GABA From Tomatoes

12 participants · First posted Sep 11, 2019

GABA and Beta-cell Regeneration

100 participants · First posted May 5, 2020

Effect of GABA on ADHD and Seizures in Children With Epilepsy.

30 participants · First posted Oct 30, 2019

Drugs

View all 465 →

KLS-GABA

GABA receptor modulators (BioCrea)

GABA program(Saniona)

Organizations

View all 199 →

University At Albany

United States

UNIVERSITY AT BUFFALO

United States

Inspiration At Work

Netherlands

News

View all 32360 →

Ovid Therapeutics' OV329 Shows 53% GABA Inhibition in Phase 1 Trial for Drug-Resistant Epilepsy

Ovid Therapeutics Advances OV329 to Phase 2 Following Positive Safety Results in Drug-Resistant Epilepsy Program

Ovid Therapeutics Advances Novel Neurological Drug Pipeline with Key Clinical Milestones Expected in 2025-2026

Page 1 of 4852